EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Seres Therapeutics, Inc. (MCRB) EBITDA Margin data is not available.
| Income Statement Financials | |
$0.74M |
|
$4.58M |
|
-- |
|
$0.74M |
|
$22.01M |
|
$-21.27M |
|
$25.85M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$-21.27M |
|
$-20.60M |
|
9.71M |
|
9.75M |
|
$0.47 |
|
$0.47 |
|
| Balance Sheet Financials | |
$42.35M |
|
$5.80M |
|
$59.24M |
|
$101.59M |
|
$20.03M |
|
-- |
|
$47.02M |
|
$67.05M |
|
$34.53M |
|
$34.53M |
|
$34.53M |
|
9.83M |
|
| Cash Flow Statement Financials | |
$-38.75M |
|
$0.01M |
|
$2.14M |
|
$54.43M |
|
$17.84M |
|
$-36.60M |
|
$3.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2890.35% |
|
-2890.35% |
|
|
EBITDA Margin |
-- |
622.42% |
|
622.42% |
|
$-38.74M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.03 |
|
3090.57 |
|
13.27% |
|
13.27% |
|
4.51% |
|
13.27% |
|
$3.51 |
|
$-3.97 |
|
$-3.98 |
|